IRVINE, Calif., Sept. 28, 2022 /PRNewswire/ -- Johnson & Johnson Vision,** a global leader in eye health and part of Johnson & Johnson MedTech,*** today announced availability of our ...
Abbott announced that the US Food and Drug Administration (FDA) has approved the Tecnis Symfony intraocular lenses for the treatment of cataracts. The first in a new category of intraocular lenses ...
Santa Ana-based Abbott Medical Optics, a unit of Abbott Laboratories in Chicago, scored a regulatory approval this month. Abbott Medical said the Food and Drug Administration approved its Tecnis ...
Abbott, a global healthcare company, has received CE Marking (Conformité Européenne) in Europe for the TECNIS Symfony Extended Range of Vision intraocular lens (IOL) for the treatment of cataract ...
A long-awaited revolution in intraocular lenses (IOLs) made its Utah and Intermountain West debut in the hands of cataract surgeon, Alan S. Crandall, MD, at the University of Utah's John A. Moran Eye ...
Please provide your email address to receive an email when new articles are posted on . IOL technology has made giant steps in recent years. Through progressive, continuous improvement, many ...
Patients now have several exciting—although not yet perfect—multifocal intraocular lenses (IOLs) for presbyopia correction from which to choose. Currently in the United States, the recently approved ...
The TECNIS® portfolio is the broadest mix of IOLs available worldwide, providing solutions for a variety of visual conditions to allow patients to See More In 2021, Johnson & Johnson Vision will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results